Wrapping up

I began writing this blog towards the beginning of 2013 with the intent of providing a place to share my exploration of regulatory intelligence as it applies to the development of medicines. At that time I was an autonomous regulatory intelligence consultant running my own business. This year I have joined the renowned and highly respected regulatory consultancy NDA, whose collective expertise is second to none, and no longer have the time to devote to this blog. For this reason, there will be no more postings on this blog. I would like to thank you personally for your interest in this blog.

Update (December 2017): I have since joined GE Healthcare as their Head of Regulatory Business Operations.

Draft definitions of regulatory intelligence

I have been attempting to come up with a succinct definition of regulatory intelligence and so far have two variants, for which I would greatly appreciate your feedback, either as a comment to this article or as an e-mail.

1. Regulatory intelligence is the process of deriving regulatory strategy from the interpretation of multiple sources of scientific and regulatory knowledge.
2. Regulatory intelligence is the process of interpreting and applying scientific and regulatory knowledge to produce regulatory strategy.

This article is an attempt to define RI in a more accurate and concise way than has been achieved to date and takes into account my previous articles on this blog on the subject.